Showing results (1441-1450 of 1,640) with videos related to

Sort By:
Pageof 164
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 3, 2010
Preoperative chemotherapy plus surgery versus surgery plus adjuvant chemotherapy versus surgery alone in early-stage non-small-cell lung cancerEnriqueta Felip, Rafael Rosell, José Antonio Maestre, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|August 20, 2025
Prognostic significance of molecular classification in high-risk endometrial cancer patients undergoing sentinel lymph node mappingLaguna Olmos Mariano, Padilla-Iserte Pablo, Diaz-Feijoo Berta, et al.
The EMBO Journal|July 1, 2018
RNase H2, mutated in Aicardi-Goutières syndrome, promotes LINE-1 retrotranspositionMaria Benitez-Guijarro, Cesar Lopez-Ruiz, Žygimantė Tarnauskaitė, et al.
Cell Surface (Amsterdam, Netherlands)|August 4, 2020
Assembly and disassembly of Aspergillus fumigatus conidial rodletsIsabel Valsecchi, Jennifer I Lai, Emmanuel Stephen-Victor, et al.
Medicina Clinica|May 24, 2025
Effect of cholecalciferol on 25-hydroxyvitamin D in people living with HIV and vitamin D deficiency: A prospective observational studyCristina Tomás, Ángeles Muñoz, Carlos Báguena, et al.
Medicina (Kaunas, Lithuania)|June 24, 2022
Patients with Invasive Lobular Carcinoma Show a Significant Increase in IRS-4 Expression Compared to Infiltrative Ductal Carcinoma-A Histopathological StudyMiguel A Ortega, Oscar Fraile-Martinez, Cielo García-Montero, et al.
ESC Heart Failure|October 9, 2020
Overexpression of endothelial β3 -adrenergic receptor induces diastolic dysfunction in ratsJustine Dhot, Marine Ferron, Valentine Prat, et al.
Biochemical Pharmacology|September 25, 2016
Standardization of the homogeneous mobility shift assay protocol for evaluation of anti-infliximab antibodies. Application of the method to Crohn's disease patients treated with infliximabB Hernández-Breijo, M Chaparro, D Cano-Martínez, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 4, 2011
A phase I pharmacokinetic and pharmacodynamic study of dalotuzumab (MK-0646), an anti-insulin-like growth factor-1 receptor monoclonal antibody, in patients with advanced solid tumorsFrancesco Atzori, Josep Tabernero, Andrés Cervantes, et al.
Journal of Personalized Medicine|February 25, 2022
Chronic Venous Disease in Pregnant Women Causes an Increase in ILK in the Placental Villi Associated with a Decrease in E-CadherinMiguel A Ortega, Chen Chaowen, Oscar Fraile-Martinez, et al.
Pageof 164